Plunkett Research Online: Invion

INVION (IVIXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Invion Ltd a clinical-stage drug development company, develops treatments for cancer. It develops a novel PhotoDynamic Therapy (PDT) for cancer. The company has produced a topical and intravenous product suitable for use in skin cancer and in solid tumours, such as ovarian, prostate and lung cancer......



Invion
Ticker: IVIXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 732950500
Fax: 61 732950599
Address: 692 High Street
East Kew, VIC 3102 Australia

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Invion Ltd a clinical-stage drug development company, develops treatments for cancer. It develops a novel PhotoDynamic Therapy (PDT) for cancer. The company has produced a topical and intravenous product suitable for use in skin cancer and in solid tumours, such as ovarian, prostate and lung cancer......See More See More

Auditor: Ernst & Young
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: